New hope for symptom management during natural and iatrogenic menopause transitions†

Teresa K. Woodruff, Sundeep Khosla
In: Biology of Reproduction · 2017 · vol. 97(2) , pp. 177–178 · doi:10.1093/biolre/iox079 · PMID:29044424 · W2738910980
article OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

Bone loss is associated with aging and is exacerbated by female transition to menopause. Estrogen has long been associated with bone loss, and replacement therapy is effective at restoring bone health. In the last 10 years, pituitary and gonadal peptide hormones have been implicated in bone biology, and here we update the story on FSH and its potential role as a direct regulator of bone and adipose. If translated to humans, new approaches to ameliorate age related bone demise could be developed. Moreover, young women with hormone responsive cancers who are unable to maintain bone may have new routes to avoid debilitating bone loss.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (10)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK